Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

Company Overview - Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company that provides innovative tools and bioactive reagents for research and clinical diagnostics [2] - The company generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people worldwide [2] Upcoming Events - Kim Kelderman, President and CEO of Bio-Techne, will present at the 2026 J.P. Morgan Healthcare Conference on January 13, 2026, at 9:00 a.m. PST [1]